The James Buchanan Brady Urological Institute
 
 
 
Paula J. Hurley, Ph.D. Paula J. Hurley, Ph.D.
Assistant Professor
Department of Urology And Oncology
Johns Hopkins University School of Medicine


Email:phurley2@jhmi.edu

The molecular basis of lethal prostate cancer

The goal of the Hurley laboratory is to reduce the death and suffering caused by aggressive prostate cancer.  To this end, the laboratory is focused on identifying novel genetic and molecular pathways driving lethal prostate cancer.  We recently identified SPARCL1 as a gene down-regulated in high-grade/ metastatic prostate cancer that is a significant, independent prognostic marker of disease progression to metastases.  The laboratory is currently examining the mechanistic roles of SPARCL1 and other mediators of aggressive prostate cancer.  In addition, the laboratory is also developing new methods for the early identification of drug resistance in metastatic patients using plasma tumor DNA and next generation technologies.                 

 



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.| Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287